drug · small molecule
patient view →crofelemer DR
Marketedupdated 2mo agoby Napo Pharmaceuticals Inc🔗 ChEMBL
Approvedcommunity read0 votes
Small molecule drug with a maximum clinical stage of Approval (across all indications), with an approval for diarrhea and 2 investigational indications.
targets
Anoctamin-1Cystic fibrosis transmembrane conductance regulator
all catalysts(0)
nothing on the calendar yet
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that